Abstract:

Introduction and Purpose: The purpose of this article is to compare the radioopathy of in-channel medications containing calcium hydroxide with current image analysis methods. Method and Requirements: In this study, three different commercial calcium hydroxide medications were used. Radiographic image data was obtained according to the International Organization for Standardization #6876: 2012 guidelines. The area to be analyzed for each sample was determined. The average (± SD) grey values of X-ray image data were measured by an image analysis software. The average grey values of samples and the grey values specified for step-wedge were converted into mmAl values by creating a calibration curve. The data was analyzed by one-way variance analysis and then by Tukey's multi-comparative test. A significant difference was made in the average radiopathy values of all medications (p<0,05). The average radioopasity values are classified as follows: TempCanal (4,94±0,31mmAl) > ProCalR (2,63±0,05mmAl) > Control (2,19±0,11mmAl). RELATED AND RESULTATED: There is a high difference between the radioopacity values of drugs containing calcium hydroxide. Although the medications showed radiopathy in the aluminum equivalent of 2.19 to 4.94 mm, only TempCanal recorded values above the aluminum equivalent of 3 mm, which is the international standard.

Keywords: